TERN — TERNS PHARMACEUTICALS INC

Ownership history in nVerses Capital, LLC  ·  5 quarters on record

This page tracks every 13F SEC filing in which nVerses Capital, LLC reported a position in TERNS PHARMACEUTICALS INC (TERN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.02% (2024 Q3)
Avg. % of fund
0.02%
First filed
2024 Q3
Last filed
2025 Q3
Quarters held
5
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 5,700 — 0% 0.02% $48K $7.51
2025 Q2 UNCHANGED 5,700 — 0% 0.02% $48K $3.73
2025 Q1 UNCHANGED 5,700 — 0% 0.02% $48K $2.76
2024 Q4 UNCHANGED 5,700 — 0% 0.02% $48K $5.54
2024 Q3 INITIATED 5,700 — — 0.02% $48K $8.34
% of Fund (quarterly)    TERN price (monthly, adj. close)

Other funds also holding TERN

As of 2025 Q4 — sorted by position size

ACORN CAPITAL ADVISORS, LLC 23.9% ACUTA CAPITAL PARTNERS, LLC 3Y 7Y 17.48% Vivo Capital, LLC 3Y 7Y 13.96% SUPERSTRING CAPITAL MANAGEMENT LP 9.6% Vestal Point Capital, LP 6.18% Ikarian Capital, LLC 3Y 5.04% Monashee Investment Management LLC 3Y 7Y 4.49% First Turn Management, LLC 4.03% Commodore Capital LP 3Y 3.97% STEMPOINT CAPITAL LP 2.97%
← Back to nVerses Capital, LLC Holdings